The FDA is currently conducting an inspection of the facility, and its preliminary findings have raised concerns about sterility assurance for all products produced and distributed by the facility.
The recall was not based on reports of patients with infections from Ameridose products, but rather a precaution since Ameridose shares common management with New England Compounding Center, the firm associated with the compounding drugs linked to the meningitis outbreak.
For a full list of Ameridose products, visit their site.
More Articles on Anesthesia:
Watching Videos Before Anesthesia Induction Reduces Stress in Children
Dicolfenac Provides Significant Pain Relief for Abdominal, Pelvic Surgeries
Can ASCs Still Profit From Anesthesia? A Review of OIG Guidance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
